Want to see IN:BODALCHEM full AI Analyst Report?
Bodal Chemicals Limited (BODALCHEM) AI Stock Analysis
Top Page
Bodal Chemicals Limited
(NSE:BODALCHEM)
The score is driven primarily by improving but still uneven financial performance (cyclical margins, meaningful leverage, and historically inconsistent free cash flow despite FY2026 improvement). Technicals are supportive due to a strong uptrend, but extremely overbought readings temper the outlook. Valuation is a headwind given the elevated P/E and no dividend yield data.
Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 20.72B
- Dividend Yield
- ―
- Average Volume (3M)
- 178.68K
- Price to Earnings (P/E)
- 30.2
- Beta (1Y)
- 1.19
- Revenue Growth
- 27.57%
- EPS Growth
- 135.05%
- Country
- India
- Employees
- 2,133
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Bodal Chemicals Limited Business Overview & Revenue Model
Company Description
Bodal Chemicals Limited, an Indian enterprise, produces and supplies a range of chemicals, including dyestuffs, dye intermediates, and various other chemical products. Its comprehensive portfolio of dye intermediates features key compounds such as vi...
Bodal Chemicals Limited Financial Statement Overview
Summary
Operational performance is improving but still inconsistent. Revenue rebounded strongly in FY2025 (+25.1%) and grew again in FY2026 (+10.0%), with net income rising to 478.3M in FY2026 from 185.0M in FY2025; however, earnings remain below the FY2022 peak and margins have swung materially across years. Leverage is meaningful (debt 8.13B vs equity 11.58B) and cash generation has been volatile, with free cash flow negative in multiple years despite a solid positive FY2026 (743.4M).
Income Statement
62PositiveBalance Sheet
55NeutralCash Flow
48Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.67B | 20.12B | 17.45B | 13.95B | 15.63B | 20.27B |
| Gross Profit | 8.19B | 7.04B | 6.76B | 1.68B | 6.70B | 5.42B |
| EBITDA | 2.07B | 1.68B | 1.69B | 1.19B | 1.45B | 2.16B |
| Net Income | 686.74M | 478.28M | 185.02M | 64.69M | 380.33M | 1.04B |
Balance Sheet | ||||||
| Total Assets | 0 | 23.56B | 23.53B | 22.88B | 21.21B | 21.22B |
| Cash, Cash Equivalents and Short-Term Investments | 212.87M | 168.45M | 360.60M | 462.50M | 225.87M | 93.95M |
| Total Debt | 0 | 8.13B | 9.11B | 8.47B | 6.98B | 5.76B |
| Total Liabilities | -11.58B | 11.98B | 12.48B | 12.06B | 10.43B | 10.70B |
| Stockholders Equity | 11.58B | 11.58B | 11.05B | 10.82B | 10.78B | 10.56B |
Cash Flow | ||||||
| Free Cash Flow | 587.21M | 743.38M | -83.36M | -407.19M | -528.49M | -1.73B |
| Operating Cash Flow | 778.82M | 1.10B | 381.14M | 2.04B | 2.85B | -135.20M |
| Investing Cash Flow | 75.41M | -13.37M | -424.34M | -2.62B | -3.10B | -1.70B |
| Financing Cash Flow | -920.92M | -1.14B | 76.36M | 809.81M | 326.55M | 1.81B |
Bodal Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Positive. The current price of 164.70 is below the 20-day moving average (MA) of 165.46, above the 50-day MA of 157.04, and above the 200-day MA of 84.71, indicating a neutral trend. The MACD of -3.85 indicates Positive momentum. The RSI at 52.44 is Neutral, neither overbought nor oversold. The STOCH value of 63.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BODALCHEM.
Bodal Chemicals Limited Peers Comparison
Overall Rating
IN:FCL69Neutral
IN:ROSSARI65Neutral- IN:BODALCHEM56.5Neutral
IN:SUDARSCHEM46Neutral
IN:CAMLINFINE30Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:FCL | 69Neutral | INR 56.58B | 40.33 | ― | 0.27% | 91.44% | 19.67% |
| IN:ROSSARI | 65Neutral | INR 22.12B | 14.48 | ― | 0.13% | 19.76% | 11.74% |
| IN:BODALCHEM | 57Neutral | INR 20.74B | 30.19 | ― | ― | 27.57% | 135.05% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:SUDARSCHEM | 46Neutral | INR 78.99B | 108.61 | ― | 0.96% | 90.13% | -6.80% |
| IN:CAMLINFINE | 30Underperform | INR 16.15B | 323.46 | ― | ― | 8.40% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:BODALCHEM | Bodal Chemicals Limited | 164.70 | 102.36 | 164.20% | |
| IN:CAMLINFINE | Camlin Fine Sciences Limited | 84.05 | -115.70 | -57.92% | |
| IN:FCL | Fineotex Chemical Limited | 48.59 | 16.55 | 51.67% | |
| IN:SUDARCOLOR | Heubach Colorants India Limited | 370.95 | -146.90 | -28.37% | |
| IN:ROSSARI | Rossari Biotech Ltd | 399.25 | -242.58 | -37.79% | |
| IN:SUDARSCHEM | Sudarshan Chemical Industries Limited | 992.15 | -150.79 | -13.19% |
Bodal Chemicals Limited Corporate Events
Bodal Chemicals Closes Insider Trading Window Ahead of September Results
Bodal Chemicals Limited, a chemicals sector company listed on BSE and NSE, manufactures and trades chemical products for industrial customers while maintaining an active presence on India’s major stock exchanges. Its operations and disclosure p...
Bodal Chemicals Denies Social Media Rumours of Merger Plan
Bodal Chemicals Limited has issued a clarification denying social media posts claiming that the company has announced a merger with a private entity to expand operations and enhance market presence. Management stated that no such amalgamation is unde...
Bodal Chemicals Sets Virtual AGM to Approve FY26 Accounts and Board Changes
Bodal Chemicals Limited has scheduled its 40th Annual General Meeting for September 25, 2026, to be conducted via video conferencing and other audio-visual means in line with regulatory allowances for virtual meetings. The company is distributing the...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 09, 2026